Observational studyMedicine2017

Comparative safety for cardiovascular outcomes of DPP-4 inhibitors versus glimepiride in patients with type 2 diabetes: A retrospective cohort study.

Hyouk-Jun Chin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.